These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29441189)

  • 21. Pathogenesis and treatment of neuroleptic malignant syndrome.
    Ebadi M; Pfeiffer RF; Murrin LC
    Gen Pharmacol; 1990; 21(4):367-86. PubMed ID: 1974219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroleptic malignant syndrome: further lessons from a case report.
    Casamassima F; Lattanzi L; Perlis RH; Litta A; Fui E; Bonuccelli U; Fricchione G; Cassano GB
    Psychosomatics; 2010; 51(4):349-54. PubMed ID: 20587766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risperidone-induced neuroleptic malignant syndrome: a case report and review.
    Meterissian GB
    Can J Psychiatry; 1996 Feb; 41(1):52-4. PubMed ID: 8919425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroleptic Malignant Syndrome/Malignant Catatonia in Child Psychiatry: Literature Review and a Case Series.
    Ghaziuddin N; Hendriks M; Patel P; Wachtel LE; Dhossche DM
    J Child Adolesc Psychopharmacol; 2017 May; 27(4):359-365. PubMed ID: 28398818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electroconvulsive Therapy in the Treatment of the Neuroleptic Malignant Syndrome.
    Davis JM; Janicak PG; Sakkas P; Gilmore C; Wang Z
    Convuls Ther; 1991; 7(2):111-120. PubMed ID: 11941110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risperidone-induced neuroleptic malignant syndrome.
    Sharma R; Trappler B; Ng YK; Leeman CP
    Ann Pharmacother; 1996; 30(7-8):775-8. PubMed ID: 8826559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electroconvulsive in a Schizophrenic Patient With Neuroleptic Malignant Syndrome and Rhabdomyolysis.
    San Gabriel MC; Eddula-Changala B; Tan Y; Longshore CT
    J ECT; 2015 Sep; 31(3):197-200. PubMed ID: 25243752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The neuroleptic malignant syndrome: occurrence in a 15-year-old boy and recovery with bromocriptine therapy.
    Tenenbein M
    Pediatr Neurosci; 1985-1986; 12(3):161-4. PubMed ID: 3870437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concurrent Electroconvulsive Therapy and Bupropion Treatment.
    Takala CR; Leung JG; Murphy LL; Geske JR; Palmer BA
    J ECT; 2017 Sep; 33(3):185-189. PubMed ID: 28570500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroleptic Malignant Syndrome: Neuroleptic Rechallenge After Electroconvulsive Therapy.
    Hanin B; Lerner Y
    Convuls Ther; 1993; 9(3):198-204. PubMed ID: 11941213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electroconvulsive therapy in drug-induced psychiatric states and neuroleptic malignant syndrome.
    Ozer F; Meral H; Aydin B; Hanoglu L; Aydemir T; Oral T
    J ECT; 2005 Jun; 21(2):125-7. PubMed ID: 15905757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapy of neuroleptic malignant syndrome.
    Lazarus A
    Psychiatr Dev; 1986; 4(1):19-30. PubMed ID: 3703852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rocuronium-sugammadex for electroconvulsive therapy management in neuroleptic malignant syndrome: A case report.
    Casas Reza P; Gestal Vázquez M; Outeiro Rosato Á; López Álvarez S; Diéguez García P
    Rev Esp Anestesiol Reanim; 2017 Feb; 64(2):105-107. PubMed ID: 27424873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroleptic malignant syndrome in a child treated with an atypical antipsychotic.
    Abu-Kishk I; Toledano M; Reis A; Daniel D; Berkovitch M
    J Toxicol Clin Toxicol; 2004; 42(6):921-5. PubMed ID: 15533033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Afebrile Neuroleptic Malignant Syndrome associated with Fluphenazine decanoate: A case report.
    Assareh M; Habibi LK
    Iran J Psychiatry; 2010; 5(2):78-80. PubMed ID: 22952496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repeated propofol anesthesia for a patient with a history of neuroleptic malignant syndrome.
    Sakamoto A; Hoshino T; Suzuki H; Kimura M; Ogawa R
    Nihon Ika Daigaku Zasshi; 1999 Aug; 66(4):262-5. PubMed ID: 10466342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clozapine: a neuroleptic at risk of provoking neuroleptic malignant syndrome (NMS) or an alternative neuroleptic with positive NMS case histories?].
    Weller M; Kornhuber J
    Fortschr Neurol Psychiatr; 1993 Jun; 61(6):217-22. PubMed ID: 8330832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant catatonia-induced respiratory failure with response to ECT.
    Boyarsky BK; Fuller M; Early T
    J ECT; 1999 Sep; 15(3):232-6. PubMed ID: 10492863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antipsychotic-induced motor symptoms in schizophrenic psychoses-Part 2 : Catatonic symptoms and neuroleptic malignant syndrome].
    Hirjak D; Sartorius A; Kubera KM; Wolf RC
    Nervenarzt; 2019 Jan; 90(1):12-24. PubMed ID: 30128733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of Expert Consultation in a Complex Case of Neuroleptic Malignant Syndrome Requiring Electroconvulsive Therapy.
    Wittenauer Welsh J; Janjua AU; Garlow SJ; McCormick L; Husain MM; Maixner DF; Weiner RD; Hermida AP
    J Psychiatr Pract; 2016 Nov; 22(6):484-489. PubMed ID: 27824784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.